Subscribe to RSS
DOI: 10.1055/s-0032-1333417
Bilateral Ptosis as Initial Presentation of Gliomatosis Cerebri: Case Report
Publication History
01 May 2012
20 October 2012
Publication Date:
20 February 2013 (online)
![](https://www.thieme-connect.de/media/jnlsa/2013S01/lookinside/thumbnails/10.1055-s-0032-1333417-1.jpg)
Abstract
Gliomatosis cerebri is a rare, diffuse glioma of neuroepithelial origin involving more than two cerebral lobes. Clinical presentation of gliomatosis cerebri is variable and depends on the degree, extent, and location of cortical involvement. Signs and symptoms related to supratentorial cortical involvement predominate and the diagnosis is reached through a combination of clinical, radiographic, and histopathological evaluations. This is a report of a young man who presented with visual problems and bilateral ptosis, which were eventually attributed to gliomatosis cerebri. Standard radiation and chemotherapy were administered but the patient eventually succumbed to the disease. The unique clinical presentation is discussed in light of this rare neoplasm of the central nervous system.
-
References
- 1 Lantos PL, Bruner JM. Gliomatosis cerebri. In: Kleihues P, Cavenee WK, , eds. Pathology and Genetics: Tumors of the Nervous System. Lyon: IARC Press; 2000: 92-93
- 2 Taillibert S, Chodkiewicz C, Laigle-Donadey F, Napolitano M, Cartalat-Carel S, Sanson M. Gliomatosis cerebri: a review of 296 cases from the ANOCEF database and the literature. J Neurooncol 2006; 76: 201-205
- 3 Vates GE, Chang S, Lamborn KR, Prados M, Berger MS. Gliomatosis cerebri: a review of 22 cases. Neurosurgery 2003; 53: 261-271 , discussion 271
- 4 del Carpio-O'Donovan R, Korah I, Salazar A, Melançon D. Gliomatosis cerebri. Radiology 1996; 198: 831-835
- 5 Asada T, Takayama Y, Tokuriki Y, Fukuyama H. Gliomatosis cerebri presenting as a parkinsonian syndrome. J Neuroimaging 2007; 17: 269-271
- 6 Belsare G, Lee AG, Maley J, Kirby P, St Louis EK, Follett K. Pseudo-subarachnoid hemorrhage and cortical visual impairment as the presenting sign of gliomatosis cerebri. Semin Ophthalmol 2004; 19: 78-80
- 7 Kararizou E, Likomanos D, Gkiatas K, Markou I, Triantafyllou N, Kararizos G. Magnetic resonance spectroscopy: a noninvasive diagnosis of gliomatosis cerebri. Magn Reson Imaging 2006; 24: 205-207
- 8 Kong DS, Kim ST, Lee JI , et al. Impact of adjuvant chemotherapy for gliomatosis cerebri. BMC Cancer 2010; 10: 424-429
- 9 Louis DN, Ohgaki H, Wiestler OD , et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007; 114: 97-109
- 10 Park S, Suh YL, Nam DH, Kim ST. Gliomatosis cerebri: clinicopathologic study of 33 cases and comparison of mass forming and diffuse types. Clin Neuropathol 2009; 28: 73-82
- 11 Fuller GN, Scheithauer BW. The 2007 revised world health organization (WHO) classification of tumours of the central nervous system: newly codified entities. Brain Pathol 2007; 17: 304-307
- 12 Clauser LC, Tieghi R, Galiè M. Palpebral ptosis: clinical classification, differential diagnosis, and surgical guidelines: an overview. J Craniofac Surg 2006; 17: 246-254
- 13 Finsterer J. Ptosis: causes, presentation, and management. Aesthetic Plast Surg 2003; 27: 193-204
- 14 Dexter MA, Parker GD, Besser M, Ell J, Fulham MJ. MR and positron emission tomography with fludeoxyglucose F 18 in gliomatosis cerebri. AJNR Am J Neuroradiol 1995; 16: 1507-1510
- 15 Bühring U, Herrlinger U, Krings T, Thiex R, Weller M, Küker W. MRI features of primary central nervous system lymphomas at presentation. Neurology 2001; 57: 393-396
- 16 Küker W, Nägele T, Korfel A , et al. Primary central nervous system lymphomas (PCNSL): MRI features at presentation in 100 patients. J Neurooncol 2005; 72: 169-177
- 17 Schaefer PW, Grant PE, Gonzalez RG. Diffusion-weighted MR imaging of the brain. Radiology 2000; 217: 331-345
- 18 Al-Okaili RN, Krejza J, Wang S, Woo JH, Melhem ER. Advanced MR imaging techniques in the diagnosis of intraaxial brain tumors in adults. Radiographics 2006; 26 (Suppl. 01) S173-S189
- 19 Horger M, Fenchel M, Nägele T , et al. Water diffusivity: comparison of primary CNS lymphoma and astrocytic tumor infiltrating the corpus callosum. AJR Am J Roentgenol 2009; 193: 1384-1387
- 20 Galanaud D, Chinot O, Nicoli F , et al. Use of proton magnetic resonance spectroscopy of the brain to differentiate gliomatosis cerebri from low-grade glioma. J Neurosurg 2003; 98: 269-276
- 21 Guzmán-de-Villoria JA, Sánchez-González J, Muñoz L , et al. 1H MR spectroscopy in the assessment of gliomatosis cerebri. AJR Am J Roentgenol 2007; 188: 710-714
- 22 Elshaikh MA, Stevens GH, Peereboom DM , et al. Gliomatosis cerebri: treatment results with radiotherapy alone. Cancer 2002; 95: 2027-2031
- 23 Perkins GH, Schomer DF, Fuller GN, Allen PK, Maor MH. Gliomatosis cerebri: improved outcome with radiotherapy. Int J Radiat Oncol Biol Phys 2003; 56: 1137-1146
- 24 Levin N, Gomori JM, Siegal T. Chemotherapy as initial treatment in gliomatosis cerebri: results with temozolomide. Neurology 2004; 63: 354-356
- 25 Sanson M, Cartalat-Carel S, Taillibert S , et al; ANOCEF group. Initial chemotherapy in gliomatosis cerebri. Neurology 2004; 63: 270-275
- 26 Glas M, Bähr O, Felsberg J , et al; Neuro-Oncology Group of the German Cancer Society. NOA-05 phase 2 trial of procarbazine and lomustine therapy in gliomatosis cerebri. Ann Neurol 2011; 70: 445-453